NTAGI for Covid-19 held a high level meeting with NITI Aayog on Wednesday as NTAGI group is sceptical about the benefits of third dose being managed.
NTAGI for Covid-19 held a high level meeting with NITI Aayog on Wednesday as NTAGI group is sceptical about the benefits of third dose being managed.